Key facts
- Medulance’s last known valuation is $13.4M (Mar 2024).
- It has raised $4.3M; the latest was Later Stage VC ($1.0M) in Jan 2026.
- Notable investors include Aman Gupta, Namita Thapar, Peyush Bansal, 3iPartners, Alkemi Growth Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Medulance
- ·The full record, as it builds
Funding rounds
No funding rounds for Medulance are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medulance
Developer of an emergency medical application designed to offer emergency ambulance services to patients. The company's platform facilitates clients facilities for all healthcare needs by delivering helpline numbers for ambulances and other healthcare services, and also provides teleconsultation, e-pharmacy, diagnostics, home health care, elderly care, and mental wellness services, enabling users to get one-touch access to medical emergency services.
- Sector
- Healthcare
- HQ
- New Delhi, India
- Founded
- 2016
- Employees
- 115
- Website
- medulance.com/
- Ownership
- Privately Held (backing)
Medulance doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medulance shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medulance in its N-PORT filings yet. We sweep new filings monthly.